Brad Jenkins

Brad provides advisory services for the healthcare industry, supporting projects involving therapies for viruses and their application to public health and pandemic preparedness.

Brad recently retired from Roche where he was Vice President of Influenza for Genentech, leading teams of commercial, medical and government affairs in support of Tamiflu and Xofluza. Brad was VP of Sales and Marketing, National Sales Director, Life Cycle Leader, Global Marketing Lead and held roles in US marketing, sales, and analytics. His work has had impact on HCV, HBV, CMV and Influenza.

Prior to Roche, Brad was a partner in start-up technology company with hardware and applications in global positioning systems. Brad also spent 9 years as a technical manager and electrical engineer at the Savannah River National Laboratory.

Brad received his B.S. in Electrical Engineering from The Ohio State University.